🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-center, open-label, multiple-dose trial in healthy p...
Status
Completed
Location
Deutsche Sporthochschule Köln
Start Date
2026-01-19
Trial ID
NCT07307794
Treatments Being Tested
The objectives of this study are to demonstrate the non-inferiority of esfl...
Status
Completed
Location
Klinik Perisai Husada
Start Date
2018-02-05
Trial ID
NCT03434197
Treatments Being Tested
Objective of this study is: to determine efficacy and safety of a Esflurbi...
Status
Completed
Location
Deutsche Sporthochschule Köln Institut für Kreislaufforschung und Sportmedizin
Start Date
2021-05-20
Trial ID
NCT04908748
Treatments Being Tested
This study is an open-label, multi-centric clinical trial to evaluate the s...
Status
Completed
Location
Medical Practice Ebert
Start Date
2025-02-20
Trial ID
NCT06871046
Treatments Being Tested
Teikoku Seiyaku Co., Ltd. (Japan) is developing a new Esflurbiprofen Hydrog...
Status
Completed
Location
SocraTec R&D GmbH, Clinical Pharmacology Unit
Start Date
2020-07-24
Trial ID
NCT04505787
Treatments Being Tested
This study is a single-center, open-label, single-dose trial performed in a...
Status
Completed
Location
SocraTec R&D GmbH Clinical Pharmacology Unit
Start Date
2025-02-28
Trial ID
NCT06870422
Treatments Being Tested
The safety and the efficacy of the Esflurbiprofen Hydrogel Patch will be as...
Status
Terminated
Location
SNBL Clinical Pharmacology Center
Start Date
2016-07
Trial ID
NCT02729207
Treatments Being Tested
This study is a multi-center, double-blind, randomized controlled trial to ...
Status
Completed
Location
Medical Practice Ebert
Start Date
2025-03-31
Trial ID
NCT06866613
Treatments Being Tested
This study is a single-center, open-label, multiple-dose trial performed in...
Status
Completed
Location
SocraTec R&D GmbH Clinical Pharmacology Unit
Start Date
2025-01-21
Trial ID
NCT06823284
Treatments Being Tested